DALCINONACOG ALFA
UNII BDB9DD09QX

Substance Identification & Data

This profile provides standardized clinical and technical data for Dalcinonacog Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BDB9DD09QX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2055206-13-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BDB9DD09QX
CAS Registry Number
2055206-13-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DALCINONACOG ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10752
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dalcinonacog Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DALCINONACOG ALFA

Common Names & Synonyms

DALCINONACOG ALFA [INN]
HUMAN BLOOD COAGULATION FACTOR IX VARIANT (R318Y, R338E, T343R), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA